Literature DB >> 9580182

[Chronic obstructive lung disease in the general population. An epidemiologic study performed in Guipúzcoa].

L Marco Jordán1, J C Martín Berra, M Corres Iñigo, R Luque Díez, G Zubillaga Garmendia.   

Abstract

To perform a cross-sectional descriptive study of chronic obstructive pulmonary disease in the general population. We studied 600 men aged between 40 and 60 from a random sample (69.9% of the total, 76.6% eligible subjects). Each subject answered a questionnaire, underwent spirometric testing and measurement of CO in expired air. Smokers accounted for 50.8% of the sample, although only 24.8% of the population had CO levels in expired air greater than 10 ppm. The prevalence of chronic bronchitis was 9.2%. Forty subjects (6.8%), only 25% of whom had previously undergone spirometry, met the criteria for air flow limitation. Air flow limitation was associated with chronic bronchitis and smoking, which were also mutually associated. Our data underline the need to combat smoking, given its relation with chronic bronchitis and airflow limitation, as well as to perform spirometry more routinely, mainly in smokers or patients with symptoms of chronic bronchitis.

Entities:  

Mesh:

Year:  1998        PMID: 9580182

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  6 in total

1.  Inappropriate overuse of inhaled corticosteroids for COPD patients: impact on health costs and health status.

Authors:  Javier de Miguel-Díez; Pilar Carrasco-Garrido; Javier Rejas-Gutierrez; Antonio Martín-Centeno; Elena Gobartt-Vázquez; Valentín Hernandez-Barrera; Miguel Angel Gil de; Rodrigo Jimenez-Garcia
Journal:  Lung       Date:  2011-04-17       Impact factor: 2.584

2.  Evaluation of a combined strategy directed towards health-care professionals and patients with chronic obstructive pulmonary disease (COPD): information and health education feedback for improving clinical monitoring and quality-of-life.

Authors:  Carles Valero; Mònica Monteagudo; Maria Llagostera; Xavier Bayona; Sílvia Granollers; Mateo Acedo; Juan J Ferro; Lluïsa Rodríguez-Latre; Jesús Almeda; Laura Muñoz
Journal:  BMC Public Health       Date:  2009-12-01       Impact factor: 3.295

3.  The influence of heart disease on characteristics, quality of life, use of health resources, and costs of COPD in primary care settings.

Authors:  Javier de Miguel-Díez; Pilar Carrasco-Garrido; Javier Rejas-Gutierrez; Antonio Martín-Centeno; Elena Gobartt-Vázquez; Valentín Hernandez-Barrera; Angel Gil de Miguel; Rodrigo Jimenez-Garcia
Journal:  BMC Cardiovasc Disord       Date:  2010-02-18       Impact factor: 2.298

Review 4.  Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review.

Authors:  Kokuvi Atsou; Christos Chouaid; Gilles Hejblum
Journal:  BMC Med       Date:  2011-01-18       Impact factor: 8.775

5.  Chronic airflow limitation in developing countries: burden and priorities.

Authors:  Nadia Aït-Khaled; Donald A Enarson; Salah Ottmani; Asma El Sony; Mai Eltigani; Ricardo Sepulveda
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

6.  Model for estimating the population prevalence of chronic obstructive pulmonary disease: cross sectional data from the Health Survey for England.

Authors:  Luis C Nacul; Michael Soljak; Tom Meade
Journal:  Popul Health Metr       Date:  2007-09-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.